Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
reslizumab | interleukin-5 | biotech | Successful target | TTD , drugbank , DGIDB | Maintenance[MeSHID:D008283] Eosinophilia[MeSHID:D004802] Asthma[MeSHID:D001249] eosinophil[MeSHID:D004804] Phenotype[MeSHID:D010641] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Pulmonary Eosinophilia[MeSHID:D011657] |
27.28 | approved,investigational | antagonist,inhibitor |
reslizumab | interleukin-5 | biotech | Successful target | TTD , drugbank , DGIDB | Maintenance[MeSHID:D008283] Eosinophilia[MeSHID:D004802] Asthma[MeSHID:D001249] eosinophil[MeSHID:D004804] Phenotype[MeSHID:D010641] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Pulmonary Eosinophilia[MeSHID:D011657] |
27.28 | approved,investigational | antagonist |
click here to return to the previous page |